 |
 |
|
|
|
|
|
|
 | | Engineering targeted therapeutics
| | Private
| | 2007
|
 |
 | | Develops novel small molecule drugs for unmet medical needs
| | Private
| | 2006
|
|
 | | Breakthrough invention to synthesize tetracycline compounds for use in antibiotics
| | Private
| | 2006
|
|
 | | Developing new treatments for celiac sprue
| | Private
| | 2006
|
|
 | | Discovery and development of therapeutics for inflammatory diseases
| | Private
| | 2006
|
|
 | | Discovery, development and commercialization of targeted therapeutics to treat cancer and other diseases
| | Private
| | 2005
|
|
 | | Develops real-time tools to monitor thermal ablation of tumors
| | Private
| | 2005
|
|
 | | Using proprietary technology developing drugs to treat musculoskeletal and metabolic disorders
| | Private
| | 2004
|
|
 | | Developing a revolutionary approach to control chemical synthesis, enabling discovery of chemical compounds and reactions on an unprecedented scale
| | Private
| | 2004
|
|
 | | Creates biologically active vascular interventions to treat significant unmet needs in cardiovascular disease
| | Private
| | 2003
|
|
 | | Product-focused biopharmaceutical company positioned to revolutionize cancer drug discovery and development [fka GenPath Pharmaceuticals]
| | Private
| | 2003
|
|
 | | CombinatoRx is creating new combination medicines that attack disease on multiple fronts
| | Private
| | 2002
|
|
 | | Develops novel kinase inhibitors for the treatment of cancer and autoimmune and inflammatory diseases [fka Cellular Gemomics]
| | Private
| | 2001
|
|
